Top compounds associated with response to NR1H2


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.05
mRNA JQ-1 GDSC1000 pan-cancer AAC 0.066 0.05
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.064 0.05
mRNA barasertib CTRPv2 pan-cancer AAC -0.063 0.05
mRNA AP-24534 GDSC1000 pan-cancer AAC 0.066 0.06
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.073 0.06
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.07 0.06
mRNA Bicalutamide GDSC1000 pan-cancer AAC 0.066 0.06
mRNA AUY922 GDSC1000 pan-cancer AAC 0.068 0.06
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC 0.14 0.06
Download CSV